Humana Specialty Pharmacy arm announced Feb. 8 that it would begin offering members Tagrisso and Lenvima, two drugs for cancer treatment.
The Latest
Patrick Phillips, CEO of Medicare Advantage technology company Cavulus, predicted in 2019 that the Medicare Advantage landscape would be disrupted by start-ups — a vision that is a reality three years later.
CVS Health saw COVID-19 expenses drop and government business rise, resulting in an 8.7 percent year-over-year increase in revenue, according to the company's year-end earnings report.
A patient can make sure their healthcare facility is in-network, but still bear a hefty bill if their providers and insurer are out of sync, said Sheldon Jacobson in a column for the Chicago Tribune.
Sacramento, Calif.-based Sutter Health is defending itself in court Feb. 9 over a class-action lawsuit accusing the provider of violating antitrust laws.
California's Health Care Services Department issued a notice Feb. 6 that removed prior authorization requirements for most drugs Under Medi-Cal, the state's Medicaid program.
UnitedHealth Group's C-suite draws experience from across the payer's portfolio and around the world.
Two U.S. senators have introduced a bill that would temporarily extend pandemic-era policies that expanded Medicare's coverage of telehealth services.
Humana has grown from a provider powerhouse in its early years into one of the largest Medicare Advantage payers in the country.
KLAS Research, a healthcare IT data and insights company, named its "Best in KLAS" payer tools for 2021.